252 related articles for article (PubMed ID: 12142368)
1. Proteomics for cancer biomarker discovery.
Srinivas PR; Verma M; Zhao Y; Srivastava S
Clin Chem; 2002 Aug; 48(8):1160-9. PubMed ID: 12142368
[TBL] [Abstract][Full Text] [Related]
2. From genomics to proteomics: techniques and applications in cancer research.
Martin DB; Nelson PS
Trends Cell Biol; 2001 Nov; 11(11):S60-5. PubMed ID: 11684444
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis in cancer research: potential application in clinical use.
García-Foncillas J; Bandrés E; Zárate R; Remírez N
Clin Transl Oncol; 2006 Apr; 8(4):250-61. PubMed ID: 16648100
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.
Findeisen P; Neumaier M
Clin Chem Lab Med; 2009; 47(6):666-84. PubMed ID: 19445650
[TBL] [Abstract][Full Text] [Related]
5. Proteomics in early detection of cancer.
Srinivas PR; Srivastava S; Hanash S; Wright GL
Clin Chem; 2001 Oct; 47(10):1901-11. PubMed ID: 11568117
[TBL] [Abstract][Full Text] [Related]
6. Affinity proteomics: the role of specific binding reagents in human proteome analysis.
Stoevesandt O; Taussig MJ
Expert Rev Proteomics; 2012 Aug; 9(4):401-14. PubMed ID: 22967077
[TBL] [Abstract][Full Text] [Related]
7. Innovative proteomic approaches for cancer biomarker discovery.
Faca V; Krasnoselsky A; Hanash S
Biotechniques; 2007 Sep; 43(3):279, 281-3, 285. PubMed ID: 17907570
[TBL] [Abstract][Full Text] [Related]
8. Clinical proteomics for cancer biomarker discovery and therapeutic targeting.
Krieg RC; Paweletz CP; Liotta LA; Petricoin EF
Technol Cancer Res Treat; 2002 Aug; 1(4):263-72. PubMed ID: 12625785
[TBL] [Abstract][Full Text] [Related]
9. Analytical validation considerations of multiplex mass-spectrometry-based proteomic platforms for measuring protein biomarkers.
Boja ES; Fehniger TE; Baker MS; Marko-Varga G; Rodriguez H
J Proteome Res; 2014 Dec; 13(12):5325-32. PubMed ID: 25171765
[TBL] [Abstract][Full Text] [Related]
10. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
Bharti A; Ma PC; Salgia R
Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
[TBL] [Abstract][Full Text] [Related]
11. Contributions of advanced proteomics technologies to cancer diagnosis.
Ciordia S; de Los Ríos V; Albar JP
Clin Transl Oncol; 2006 Aug; 8(8):566-80. PubMed ID: 16952845
[TBL] [Abstract][Full Text] [Related]
12. The Implementation of Mass Spectrometry-Based Proteomics Workflows in Clinical Routines of Acute Myeloid Leukemia: Applicability and Perspectives.
Hernandez-Valladares M; Bruserud Ø; Selheim F
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957646
[TBL] [Abstract][Full Text] [Related]
13. New cancer biomarkers deriving from NCI early detection research.
Verma M; Srivastava S
Recent Results Cancer Res; 2003; 163():72-84; discussion 264-6. PubMed ID: 12903844
[TBL] [Abstract][Full Text] [Related]
14. Optomechanical devices for deep plasma cancer proteomics.
Kosaka PM; Calleja M; Tamayo J
Semin Cancer Biol; 2018 Oct; 52(Pt 1):26-38. PubMed ID: 28867489
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and Predictive Biomarkers in Cancer.
Nair M; Sandhu SS; Sharma AK
Curr Cancer Drug Targets; 2014; 14(5):477-504. PubMed ID: 24807144
[TBL] [Abstract][Full Text] [Related]
16. Contribution of oncoproteomics to cancer biomarker discovery.
Cho WC
Mol Cancer; 2007 Apr; 6():25. PubMed ID: 17407558
[TBL] [Abstract][Full Text] [Related]
17. Recent progress in mass spectrometry proteomics for biomedical research.
Li X; Wang W; Chen J
Sci China Life Sci; 2017 Oct; 60(10):1093-1113. PubMed ID: 29039124
[TBL] [Abstract][Full Text] [Related]
18. Sample preparation and fractionation for proteome analysis and cancer biomarker discovery by mass spectrometry.
Ahmed FE
J Sep Sci; 2009 Mar; 32(5-6):771-98. PubMed ID: 19219839
[TBL] [Abstract][Full Text] [Related]
19. Inconvenient truth: cancer biomarker development by using proteomics.
Kondo T
Biochim Biophys Acta; 2014 May; 1844(5):861-5. PubMed ID: 23896458
[TBL] [Abstract][Full Text] [Related]
20. Discovery and Validation of Clinical Biomarkers of Cancer: A Review Combining Metabolomics and Proteomics.
Srivastava A; Creek DJ
Proteomics; 2019 May; 19(10):e1700448. PubMed ID: 30353665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
